Paper34603306
Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.
Carriquiriborde F and 9 others. Front Immunol, 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture. Papers, record 34603306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34603306
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Outer Membrane | Major topic |
| Biofilms | Major topic |
| Bordetella pertussis | Major topic |
| Extracellular Vesicles | Major topic |
| Pertussis Vaccine | Major topic |
| Whooping Cough | Major topic |
| Animals | |
| Bacterial Outer Membrane Proteins | |
| Disease Models, Animal | |
| Female | |
| Immunization | |
| Immunogenicity, Vaccine | |
| Mice, Inbred BALB C | |
| Vaccine Development | |
| Virulence Factors, Bordetella | |
| Mice |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24256623 | Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. | Clin Vaccine Immunol | 2014 | https://conductscience.org/library/papers/24256623 | PubMed |
| 2 | 28533445 | Lung CD4 Tissue-Resident Memory T Cells Mediate Adaptive Immunity Induced by Previous Infection of Mice with Bordetella pertussis. | J Immunol | 2017 | https://conductscience.org/library/papers/28533445 | PubMed |
| 3 | 26763701 | The pertussis enigma: reconciling epidemiology, immunology and evolution. | Proc Biol Sci | 2016 | https://conductscience.org/library/papers/26763701 | PubMed |
| 4 | 28893915 | Hyperbiofilm Formation by Bordetella pertussis Strains Correlates with Enhanced Virulence Traits. | Infect Immun | 2017 | https://conductscience.org/library/papers/28893915 | PubMed |
| 5 | 2906641 | Use of supplemented Stainer-Scholte broth for the isolation of Bordetella pertussis from clinical material. | J Clin Microbiol | 1988 | https://conductscience.org/library/papers/2906641 | PubMed |
| 6 | 25988566 | Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity. | J Proteome Res | 2015 | https://conductscience.org/library/papers/25988566 | PubMed |
| 7 | 31106160 | A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains. | Front Cell Infect Microbiol | 2019 | https://conductscience.org/library/papers/31106160 | PubMed |
| 8 | 26432908 | Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. | Vaccine | 2015 | https://conductscience.org/library/papers/26432908 | PubMed |
| 9 | 26038752 | The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins. | Emerg Microbes Infect | 2014 | https://conductscience.org/library/papers/26038752 | PubMed |
| 10 | 25136948 | Pertussis: still a cause of death, seven decades into vaccination. | Curr Opin Pediatr | 2014 | https://conductscience.org/library/papers/25136948 | PubMed |
| 11 | 25316461 | Pertussis. A reemerging and an underreported infectious disease. | Saudi Med J | 2014 | https://conductscience.org/library/papers/25316461 | PubMed |
| 12 | 24757216 | Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. | mBio | 2014 | https://conductscience.org/library/papers/24757216 | PubMed |
| 13 | 25133400 | Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model. | PLoS One | 2014 | https://conductscience.org/library/papers/25133400 | PubMed |
| 14 | 22471652 | Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. | J Appl Microbiol | 2012 | https://conductscience.org/library/papers/22471652 | PubMed |
| 15 | 25424954 | Development of improved pertussis vaccine. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/25424954 | PubMed |
| 16 | 4324651 | A simple chemically defined medium for the production of phase I Bordetella pertussis. | J Gen Microbiol | 1970 | https://conductscience.org/library/papers/4324651 | PubMed |
| 17 | 18972542 | Proteome approaches combined with Fourier transform infrared spectroscopy revealed a distinctive biofilm physiology in Bordetella pertussis. | Proteomics | 2008 | https://conductscience.org/library/papers/18972542 | PubMed |
| 18 | 32973778 | Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From Bordetella pertussis. | Front Immunol | 2020 | https://conductscience.org/library/papers/32973778 | PubMed |
| 19 | 24485284 | Do we need a new vaccine to control the re-emergence of pertussis? | Trends Microbiol | 2014 | https://conductscience.org/library/papers/24485284 | PubMed |
| 20 | 27151884 | Characterization of the immune response induced by pertussis OMVs-based vaccine. | Vaccine | 2016 | https://conductscience.org/library/papers/27151884 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923054 | Biofilm-associated healthcare-associated infections: mechanisms, clinical burden, and emerging therapeutic frontiers - a narrative review. | GMS Hyg Infect Control | 2026 | https://conductscience.org/library/papers/42923054 | PubMed |
| 41789105 | Bacterial EVs contain small RNAs and transfer RNAs that regulate inflammation in lung infections. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789105 | PubMed |
| 40963598 | Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines. | Front Immunol | 2025 | https://conductscience.org/library/papers/40963598 | PubMed |
| 39669568 | Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/39669568 | PubMed |
| 39406780 | A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39406780 | PubMed |
| 39126548 | Protective Activity and Safety of Experimental Acellular Pertussis Vaccines Based on Antigenic Complexes Isolated from Biofilm and Planktonic Cultures of Bordetella pertussis. | Bull Exp Biol Med | 2024 | https://conductscience.org/library/papers/39126548 | PubMed |
| 38564339 | Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/38564339 | PubMed |
| 38107868 | Identification of genes involved in enhanced membrane vesicle formation in Pseudomonas aeruginosa biofilms: surface sensing facilitates vesiculation. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38107868 | PubMed |
| 37999346 | Latest Update on Outer Membrane Vesicles and Their Role in Horizontal Gene Transfer: A Mini-Review. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37999346 | PubMed |
| 37755174 | Bacterial Outer Membrane Vesicles and Immune Modulation of the Host. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/37755174 | PubMed |
| 37601354 | Integrating proteomic data with metabolic modeling provides insight into key pathways of Bordetella pertussis biofilms. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37601354 | PubMed |
| 37091673 | Understanding bacterial biofilms: From definition to treatment strategies. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37091673 | PubMed |
| 36047634 | Bordetella pertussis and outer membrane vesicles. | Pathog Glob Health | 2023 | https://conductscience.org/library/papers/36047634 | PubMed |
| 35402394 | Biological Nanoparticles in Vaccine Development. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/35402394 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34603306
GET https://conductscience.org/api/papers/v1/34603306/references?page=2